» Articles » PMID: 14990420

Transfer of Inflammatory Cytokines Across the Placenta

Overview
Journal Obstet Gynecol
Date 2004 Mar 3
PMID 14990420
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to determine whether the placental transfer of interleukin (IL)-1alpha, IL-6, and tumor necrosis factor-alpha (TNF-alpha) occurs.

Methods: Four normal-term placentas were perfused for maternal-fetal transfer of the cytokines, 2 placentas for fetal-maternal transfer, and 4 additional placentas were used for an endogenous control. The ex vivo isolated cotyledon human placental perfusion model was used. The reference compound antipyrine was used to determine the transport fraction and clearance index of the cytokines. The cytokines were added to either the maternal or fetal circulations, and samples were collected for 1 hour in a constant-flow open circulation. Cytokine levels were compared between the study and control placentas. Concentrations of the cytokines were measured by sandwich enzyme immunoassay.

Results: The clearance index for the maternal-fetal transfer of IL-1alpha and TNF-alpha was 0.001, suggesting minimal transfer to the fetal circulation. The clearance index for IL-6 was 0.30, indicating transfer to the fetal circulation. When the cytokines were added to the fetal circulation, the clearance index for IL-1alpha was 0.001, again indicating minimal transfer. The clearance index for TNF-alpha in the fetal-maternal study was not determined. IL-6 had a clearance index of 0.23, which was similar to that observed with maternal-fetal transfer. IL-6 concentrations in the study placentas were higher than the concentrations found in the controls.

Conclusion: There appears to be bidirectional transfer of IL-6 in the healthy-term human placental perfusion model.

Level Of Evidence: II-2

Citing Articles

Maternal Obesity and Neurodevelopment of the Offspring.

Eleftheriades A, Koulouraki S, Belegrinos A, Eleftheriades M, Pervanidou P Nutrients. 2025; 17(5).

PMID: 40077761 PMC: 11901708. DOI: 10.3390/nu17050891.


Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance.

Diaz-Pons A, Castano-Castano S, Ortiz-Garcia de la Foz V, Yorca-Ruiz A, Martinez-Asensi C, Munarriz-Cuezva E Brain Behav Immun Health. 2025; 44:100956.

PMID: 39990281 PMC: 11846590. DOI: 10.1016/j.bbih.2025.100956.


The effects of prenatal administration of tumor necrosis factor-α on osteocalcin and RANK expression in newborn mice.

Basiri M, Mortezazadeh F, Nematollahi-Mahani S, Haratizadeh S J Mol Histol. 2025; 56(2):76.

PMID: 39878799 DOI: 10.1007/s10735-025-10354-1.


Prenatal exposure to maternal hypertension and higher body mass index and risks of neurodevelopmental and psychiatric disorders during childhood.

Nivins S, Kumar P, Chen X, Gissler M, Lavebratt C Acta Obstet Gynecol Scand. 2024; 104(2):319-330.

PMID: 39611242 PMC: 11782093. DOI: 10.1111/aogs.15021.


The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders.

Kim D, Croen L, Iosif A, Ames J, Alexeeff S, Qian Y Brain Behav Immun. 2024; 123:1071-1080.

PMID: 39532198 PMC: 11684471. DOI: 10.1016/j.bbi.2024.11.014.